Target intelligence / Profile preview

Centrin-3 (CETN3)

Target
CETN3
Molecular classification
EF-hand domain–containing protein, Centrin family protein, Structural calcium-binding protein
01

Overview

Centrin-3 (CETN3) is a small, evolutionarily conserved calcium-binding protein belonging to the EF-hand superfamily, highly homologous to yeast CDC31 and found abundantly at the centrosome in mammalian cells[2][3]. It contains four EF-hand domains and functions as a calcium sensor, regulating centriole duplication and centrosome assembly through interaction and inhibitory regulation of Mps1 kinase activity[1][2][3]. Upon calcium binding, Centrin-3 undergoes conformational changes that facilitate its interaction with target peptides such as XPC and Kar1, modulating protein–protein interactions critical for centrosome function, genomic stability, and cell cycle progression[1][2]. Dysregulation of CETN3, including suppression via microRNA-410, has been implicated in certain cancer types and may contribute to tumorigenesis in a context-dependent manner[2][3]. Alternative splicing generates several isoforms of Centrin-3, but no functional redundancy with Centrin-2 has been observed in vertebrates[1].

Other names
CEN3CDC31 yeast homologEF-hand protein 3Centrin-3CDC31
02

Biological functions

Calcium bindingCentrosome assemblyRegulation of centriole duplicationCell cycle regulationProtein–protein interactions (including inhibition of Mps1 kinase activity; interaction with XPC and Kar1 at centrosome)
03

Disease associations

Cancer (dysregulation contributes to tumorigenesis via miR-410-mediated suppression, as reported in recent oncology studies)Associations with iris spindle cell melanoma and malignant ciliary body melanoma

Beyond the preview

Go deeper on Centrin-3 (CETN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centrin-3 (CETN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call